enGene Therapeutics Inc.
ENGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001980845
In the last 90 days, enGene Therapeutics Inc. insiders filed 1 open-market purchase and 0 sales; 60 institutions reported holding it in 13F filings for Q2 2026, worth $86.5M in total; no superinvestor holds it.
Other share classesENGNW
13F holders, Q4 2025
Institutional positions in enGene Therapeutics Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- +21 vs. Q3 2025
- Shares held
- 58.8M
- +17.9M (+43.9%) vs. Q3 2025
- Total value
- $530.8M
- +$251.8M (+90.2%) vs. Q3 2025
- New holders
- 27
- 17 more added
- Sold out
- 6
- 8 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $86.5M |
| Q1 2026 | 62 | $383.0M |
| Q4 2025 | 58 | $530.8M |
| Q3 2025 | 37 | $279.1M |
| Q2 2025 | 36 | $147.1M |
| Q1 2025 | 31 | $183.4M |
| Q4 2024 | 34 | $274.7M |
| Q3 2024 | 30 | $227.7M |
| Q2 2024 | 30 | $307.1M |
| Q1 2024 | 31 | $536.1M |
| Q4 2023 | 11 | $130.9M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding enGene Therapeutics Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FCPM III Services B.V. | 9,632,561 | $87.0M | 11.40% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 5,869,076 | $53.0M | 0.97% | +3,771,840+179.8% | Added |
| VR Adviser, LLC | 4,771,414 | $43.1M | 2.13% | −275,000−5.4% | Reduced |
| Deep Track Capital, LP | 4,377,572 | $39.5M | 0.90% | +2,138,219+95.5% | Added |
| Cormorant Asset Management, LP | 4,000,000 | $36.1M | 2.05% | +1,676,405+72.1% | Added |
| Blue Owl Capital Holdings LP | 3,360,937 | $30.3M | 9.37% | +82,831+2.5% | Added |
| Siren, L.L.C. | 3,336,264 | $30.1M | 0.90% | +3,336,264 | New |
| Braidwell LP | 3,131,319 | $28.3M | 0.90% | +865,000+38.2% | Added |
| Nextech Invest, Ltd. | 2,124,943 | $19.2M | 1.85% | +2,124,943 | New |
| Janus Henderson Group PLC | 1,900,000 | $17.1M | 0.01% | +1,900,000 | New |
| MPM Oncology Impact Management LP | 1,840,898 | $16.6M | 1.90% | +1,310,599+247.1% | Added |
| Millennium Management LLC | 1,499,520 | $13.5M | 0.01% | +1,479,018+7,214.0% | Added |
| Kynam Capital Management, LP | 1,492,898 | $13.5M | 0.88% | −3,501,192−70.1% | Reduced |
| Franklin Resources Inc | 1,388,000 | $12.5M | 0.00% | +350,000+33.7% | Added |
| Polar Capital Holdings Plc | 1,142,982 | $10.3M | 0.05% | +1,142,982 | New |
| Vestal Point Capital, LP | 1,055,000 | $9.53M | 0.35% | +685,000+185.1% | Added |
| Eventide Asset Management, LLC | 950,000 | $8.58M | 0.13% | +950,000 | New |
| Omega Fund Management, LLC | 876,357 | $7.91M | 2.76% | +350,000+66.5% | Added |
| Sr One Capital Management, LP | 747,750 | $6.75M | 0.96% | 00.0% | Unchanged |
| Morgan Stanley | 718,485 | $6.49M | 0.00% | +283,194+65.1% | Added |
| Affinity Asset Advisors, LLC | 643,370 | $5.81M | 0.42% | +566,370+735.5% | Added |
| Point72 Asset Management, L.P. | 561,797 | $5.07M | 0.01% | −646,602−53.5% | Reduced |
| Eversept Partners, LP | 455,835 | $4.12M | 0.23% | +455,835 | New |
| Privium Fund Management B.V. | 352,087 | $3.18M | 0.59% | +352,087 | New |
| Marshall Wace, LLP | 343,928 | $3.11M | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 303,686 | $2.74M | 0.21% | +303,686 | New |
| Monashee Investment Management LLC | 295,000 | $2.66M | 1.50% | +295,000 | New |
| Woodline Partners LP | 250,000 | $2.26M | 0.01% | +250,000 | New |
| Elmind Capital, LP | 210,000 | $1.90M | 0.56% | +210,000 | New |
| DAFNA Capital Management LLC | 163,645 | $1.48M | 0.34% | +163,645 | New |
| Two Sigma Investments, LP | 161,512 | $1.46M | 0.00% | +161,512 | New |
| Goldman Sachs Group Inc | 147,889 | $1.34M | 0.00% | +287+0.2% | Added |
| Deeter Investments LLP | 90,000 | $812.7K | 0.18% | +90,000 | New |
| Kennedy Capital Management, Inc. | 76,765 | $693.2K | 0.01% | +76,765 | New |
| HRT Financial LP | 64,380 | $581.0K | 0.00% | +64,380 | New |
| Jane Street Group, LLC | 56,454 | $509.8K | 0.00% | +56,454 | New |
| Quadrature Capital Ltd | 48,583 | $438.7K | 0.00% | +48,583 | New |
| BNP Paribas Arbitrage, SA | 35,877 | $324.0K | 0.00% | +35,877 | New |
| Virtus Investment Advisers, Inc. | 31,445 | $283.9K | 0.08% | +31,445 | New |
| Northern Trust Corp | 30,085 | $271.7K | 0.00% | −210−0.7% | Reduced |
| Geode Capital Management, LLC | 29,018 | $262.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 25,383 | $229.2K | 0.00% | −32,987−56.5% | Reduced |
| Pale Fire Capital SE | 24,004 | $216.8K | 0.03% | +6,750+39.1% | Added |
| American Century Companies Inc | 23,980 | $216.5K | 0.00% | +23,980 | New |
| XTX Topco Ltd | 23,922 | $216.0K | 0.01% | +23,922 | New |
| Renaissance Technologies LLC | 20,782 | $187.7K | 0.00% | +20,782 | New |
| Raymond James Financial Inc | 19,960 | $180.2K | 0.00% | +9,960+99.6% | Added |
| Two Sigma Advisers, LP | 17,300 | $156.2K | 0.00% | +17,300 | New |
| Schonfeld Strategic Advisors LLC | 16,645 | $150.3K | 0.00% | −8,425−33.6% | Reduced |
| Jump Financial, LLC | 13,400 | $121.0K | 0.00% | +13,400 | New |
| Wells Fargo & Company | 11,217 | $101.3K | 0.00% | −6,693−37.4% | Reduced |
| PFS Partners, LLC | 11,000 | $99.3K | 0.05% | +2,000+22.2% | Added |
| Royal Bank of Canada | 7,915 | $71.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,614 | $23.6K | 0.00% | +2,614 | New |
| Citigroup Inc | 1,688 | $15.2K | 0.00% | +1,687+168,700.0% | Added |
| UBS Group AG | 1,597 | $14.4K | 0.00% | +1,597 | New |
| MAI Capital Management | 776 | $7.01K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 28 | $253 | 0.00% | −3−9.7% | Reduced |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −1,157,380−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −647,192−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −504,409−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −11,074−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |